Clinical Trial Update: SC12267 (4SC-101) in Combination With Methotrexate in Patients With Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating SC12267 (4SC-101) in combination with methotrexate for rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• SC12267 (4SC-101) (SC12267)

Snippet

Sponsor: 4SC AG | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED